MARKET

ALVO

ALVO

Alvotech
NASDAQ
3.710
+0.090
+2.49%
Pre Market: 3.730 +0.02 +0.54% 04:05 04/14 EDT
OPEN
3.580
PREV CLOSE
3.620
HIGH
3.740
LOW
3.550
VOLUME
1
TURNOVER
0
52 WEEK HIGH
11.85
52 WEEK LOW
3.030
MARKET CAP
1.16B
P/E (TTM)
38.49
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ALVO last week (0406-0410)?
Weekly Report · 22h ago
Alvotech: Improving Fundamentals Signal A Potential Bottom For This Biosimilar Player
Seeking Alpha · 3d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 6d ago
Mach Natural Resources, Mesoblast And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Benzinga · 6d ago
Weekly Report: what happened at ALVO last week (0330-0403)?
Weekly Report · 04/06 09:53
Alvotech Earnings Call: Growth Momentum Meets FDA Risk
TipRanks · 04/02 00:06
Why nCino Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Benzinga · 04/01 09:27
Alvotech announces availability of fiscal 2025 Form 20-F annual report
Reuters · 03/31 00:03
More
About ALVO
Alvotech SA is a biotechnology company. The Company is focused on the development and manufacture of biosimilar medicines for patients globally. It is engaged in developing a pipeline of monoclonal antibodies that target a variety of therapeutic areas including inflammatory diseases, oncology, and ophthalmology. The Company’s pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Its products pipeline includes AVT02, AVT04, AVT23, AVT03, AVT05, AVT06, AVT16, and AVT33. Its AVT02 is a monoclonal antibody and a biosimilar to Humira (adalimumab). AVT04 is a monoclonal antibody and a biosimilar candidate to Stelara (ustekinumab). It has formed a network of strategic commercial partnerships to provide global reach and leverage expertise in markets that include the United States (U.S.), Europe, Japan, China, and other Asian countries and large parts of South America, Africa, and the Middle East.

Webull offers Alvotech SA stock information, including NASDAQ: ALVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALVO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALVO stock methods without spending real money on the virtual paper trading platform.